Received Aldomet since [**2163-3-23**].
Fetal growth restriction; mother received RhoGAM [**2163-2-15**].
Due to decreasing amniotic fluid volume and ongoing fetal restriction, the decision was made to deliver the infant by cesarean section for breech positioning.
The infant was not treated with methylxanthine therapy.
Fluids, Electrolytes and Nutrition:  The infant was started on enteral feedings of breast milk or Enfamil 20 calories per ounce p.o.
The infant required gavage feedings until day of life nine.
The infant tolerated feeding advancement without difficulty.
GI:  The infant did not receive phototherapy this hospitalization.
Hematology:  The infant did not receive any blood transfusions this hospitalization.
Infectious Disease:  Delivery was due to maternal pregnancy-induced hypertension.
The infant did not receive antibiotics this hospitalization.
Feeding:  At discharge, NeoSure 24 calories per ounce p.o., minimum 140 cc per kilogram per day or breast milk 24 calories per ounce mixed with 4 calories per ounce of NeoSure Powder.
Immunizations received - none.
The infant should receive the first Hepatitis B Vaccine at 2 kg or 2 months of age (whichever is first).
According to AAP guidelines, an outpatient hip ultrasound is recommended due to several risk factors for developmental dysplasia of the hip (DDH) including: breech presentation, female, prematurity and cesarean section.
